| Literature DB >> 23182806 |
Jennifer Meyer1, David Fardo, Steven T Fleming, Claudia Hopenhayn, Yevgeniya Gokun, Melody Ryan.
Abstract
The use of generic antiepileptic drugs (AEDs) in patients with epilepsy is controversial. The purpose of this study is to identify patient characteristics associated with increased odds of receiving a generic AED product. A large commercial database was used to identify patients with a primary diagnosis of epilepsy who were prescribed an AED during a three-month window. Data analysis found that those ≥65 years old had 15.7% greater odds of receiving a generic AED (OR = 1.157; 95% CI = 1.056-1.268). Patients with Medicaid were found to have 2.44 times the odds of having had a generic AED prescription (OR = 2.44; CI = 2.168-2.754). Patients residing in the Northeast had 12.6% decreased odds of receiving a generic AED (OR = 0.874; C I= 0.821-0.931). These patient characteristics could signify certain health care disparities and may represent potential confounders to future observational studies. Published by Elsevier Inc.Entities:
Mesh：
Substances：
Year: 2012 PMID： 23182806 PMCID： PMC4278569 DOI： 10.1016/j.yebeh.2012.10.010
Source DB: PubMed Journal: Epilepsy Behav ISSN： 1525-5050 Impact factor: 3.337